VISENTIN, Sonia
VISENTIN, Sonia
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
2016-01-01 Giordano, S; Morosi, L; Veglianese, P; Licandro, S A; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E
A KINETIC STUDY BY STOPPED FLOW OF THE INTERACTION BETWEEN POTENTIAL PHOTOSENSITIZERS AND ALBUMIN
2014-01-01 Sonja Visentin ; Nadia Barbero ; Guido Viscardi
A kinetic study of the interaction between potential photosensitizers and albumin
2013-01-01 Sonja Visentin ; Nadia Barbero; Guido Viscardi ; Giulia Caron ; Giuseppe Ermondi
A New Synthetic Approach to Substituted β-Carboline Systems
1999-01-01 GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
A study of the interaction between mucin and pristine or functionalized carbon nanotubes
2013-01-01 Sonja Visentin; Nadia Barbero; Luca Bonadini; Marco Marenchino; Simona Oliaro Bosso; Guido Viscardi
Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS
2011-01-01 C. Medana; S. Visentin; F. Dal Bello; V. Giancotti; R. Mastrocola ; M. Aragno; C. Baiocchi
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation
2012-01-01 Guglielmotto M; Aragno M; Tamagno E; Vercellinatto I; Visentin S; Medana C; Catalano MG; Smith MA; Perry G; Danni O; Boccuzzi G; Tabaton M.
Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery
2017-01-01 Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S
Application of 3D Mass Spectrometry Imaging to TKIs
2017-01-01 Morosi, L.; Giordano, S.; Falcetta, F.; Frapolli, R.; Licandro, S. A.; Matteo, C.; Zucchetti, M.; Ubezio, P.; Erba, E.; Visentin, S.; D'Incalci, M.; Davoli, E.
Application of in silico classical drug discovery tools for peptide research
2013-01-01 Ermondi, Giuseppe; Esposito, Roberto; Visconti, Alessia; Visentin, Sonja; Vallaro, Maura; Rinaldi, Laura; Caron, Giulia
APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH
2013-01-01 G. Ermondi; R. Esposito; A. Visconti; S. Visentin; M. Vallaro; L. Rinaldi; G. Caron
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists
2000-01-01 SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists
2000-01-01 S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco
Atmospheric pressure plasma as a green tool for surface modification and functionalization
2011-01-01 N. Barbero; L. Bonandini; C. Barolo; P. Quagliotto; S. Visentin; G. Viscardi
A biosimilar mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies
2018-01-01 Cosmin Butnarasu, Maura Vallaro, Daniela Pacheco, Paola Petrini, Livia Visai, Sonja Visentin
Blended-learning for courses in Pharmaceutical Analysis
2011-01-01 Giulia Caron; Sonja Visentin; Giuseppe Ermondi
Blended-learning for courses in Pharmaceutical Analysis. Part 2
2013-01-01 Visentin S; Ermondi G; Vallaro M; Scalet G; Caron G
Carbon nanodots as delivery system for Squaraines: an in vitro study to investigate their Photodynamic activity
2019-01-01 Cosmin Butnarasu, Edoardo Di Gioia, Giorgia Delsoglio, Giorgia Chinigò, Alessandra Fiorio Pla, Nadia Barbero, Sonja Visentin
Carbon nanodots as nanocarrier for Squaraines: an in vitro evaluation of their Photodynamic activity
2021-01-01 C. Butnarasu, C. Pontremoli, M.J. Moràn Plata, E. Sansone, G. Chinigò, A. Fiorio Pla, N. Barbero, S. Visentin
Carbon nanotubes for targeted drug delivery
2009-01-01 Chiara Biale; Valentina Mussi; Ugo Valbusa; Sonja Visentin; Guido Viscardi; Nadia Barbero; Nicoletta Pedemonte; Luis Galietta
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors | 2016 | Giordano, S; Morosi, L; Veglianese, P; Licandro, S A; Frapolli, R; Zucchetti, M; Cappelletti, G; Falciola, L; Pifferi, V; Visentin, S; D'Incalci, M; Davoli, E | |
| A KINETIC STUDY BY STOPPED FLOW OF THE INTERACTION BETWEEN POTENTIAL PHOTOSENSITIZERS AND ALBUMIN | 2014 | Sonja Visentin ; Nadia Barbero ; Guido Viscardi | |
| A kinetic study of the interaction between potential photosensitizers and albumin | 2013 | Sonja Visentin ; Nadia Barbero; Guido Viscardi ; Giulia Caron ; Giuseppe Ermondi | |
| A New Synthetic Approach to Substituted β-Carboline Systems | 1999 | GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO | |
| A study of the interaction between mucin and pristine or functionalized carbon nanotubes | 2013 | Sonja Visentin; Nadia Barbero; Luca Bonadini; Marco Marenchino; Simona Oliaro Bosso; Guido Viscardi | |
| Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS | 2011 | C. Medana; S. Visentin; F. Dal Bello; V. Giancotti; R. Mastrocola ; M. Aragno; C. Baiocchi | |
| AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation | 2012 | Guglielmotto M; Aragno M; Tamagno E; Vercellinatto I; Visentin S; Medana C; Catalano MG; Smith MA; Perry G; Danni O; Boccuzzi G; Tabaton M. | |
| Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery | 2017 | Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S | |
| Application of 3D Mass Spectrometry Imaging to TKIs | 2017 | Morosi, L.; Giordano, S.; Falcetta, F.; Frapolli, R.; Licandro, S. A.; Matteo, C.; Zucchetti, M.; Ubezio, P.; Erba, E.; Visentin, S.; D'Incalci, M.; Davoli, E. | |
| Application of in silico classical drug discovery tools for peptide research | 2013 | Ermondi, Giuseppe; Esposito, Roberto; Visconti, Alessia; Visentin, Sonja; Vallaro, Maura; Rinaldi, Laura; Caron, Giulia | |
| APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH | 2013 | G. Ermondi; R. Esposito; A. Visconti; S. Visentin; M. Vallaro; L. Rinaldi; G. Caron | |
| Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists | 2000 | SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO | |
| Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists | 2000 | S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco | |
| Atmospheric pressure plasma as a green tool for surface modification and functionalization | 2011 | N. Barbero; L. Bonandini; C. Barolo; P. Quagliotto; S. Visentin; G. Viscardi | |
| A biosimilar mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies | 2018 | Cosmin Butnarasu, Maura Vallaro, Daniela Pacheco, Paola Petrini, Livia Visai, Sonja Visentin | |
| Blended-learning for courses in Pharmaceutical Analysis | 2011 | Giulia Caron; Sonja Visentin; Giuseppe Ermondi | |
| Blended-learning for courses in Pharmaceutical Analysis. Part 2 | 2013 | Visentin S; Ermondi G; Vallaro M; Scalet G; Caron G | |
| Carbon nanodots as delivery system for Squaraines: an in vitro study to investigate their Photodynamic activity | 2019 | Cosmin Butnarasu, Edoardo Di Gioia, Giorgia Delsoglio, Giorgia Chinigò, Alessandra Fiorio Pla, Nadia Barbero, Sonja Visentin | |
| Carbon nanodots as nanocarrier for Squaraines: an in vitro evaluation of their Photodynamic activity | 2021 | C. Butnarasu, C. Pontremoli, M.J. Moràn Plata, E. Sansone, G. Chinigò, A. Fiorio Pla, N. Barbero, S. Visentin | |
| Carbon nanotubes for targeted drug delivery | 2009 | Chiara Biale; Valentina Mussi; Ugo Valbusa; Sonja Visentin; Guido Viscardi; Nadia Barbero; Nicoletta Pedemonte; Luis Galietta |